FDA OKs less-abusable Oxy

The U.S. Food and Drug Administration has approved a new formulation of controlled-release OxyContin that is intended to make the powerful painkiller harder to abuse. The new formulation will most likely result in less abuse by inhaling or injection, but can still be abused or misused by ingesting larger doses than are recommended, the agency said.

Purdue Pharma LP, OxyContin’s maker, admits that “there is no evidence that the reformulation of OxyContin is less subject to misuse, abuse, diversion, overdose or addiction.”

About Erin Marie Daly

I’m a freelance journalist based in San Francisco. My book on prescription drug and heroin addiction was published in August 2014 by Counterpoint Press.
This entry was posted in Pharmaceutical Industry, Policy & Regulation and tagged , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *